- Adults (18-64 years)
- Elderly (≥65 years)
- People at high risk of STIs
- PrEP users
- Hospital
- Community
- Primary care
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- Sexually transmitted infection
- Syphilis
- Pharmacological intervention
- PrEP-bSTI
Population: Adults (18-64 years)
- Adults (18-64 years)
- Elderly (≥65 years)
- Travelers
- Hospital
- Emergency department
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- Zika virus
- Arboviral disease
- Vector-borne disease
- Adults (18-64 years)
- Elderly (≥65 years)
- Travelers
- Community
- Telemedicine
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- West Nile virus
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Non pharmacological intervention
- Digital health
- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Emergency department
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- Zika virus
- West Nile virus
- Japanese encephalitis virus
- Arboviral disease
- Vector-borne disease
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- Elderly (≥65 years)
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-acute infection syndrome
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Oxygen therapy
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Immunoadsorption
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Neuromodulation